| Market Cap | ₹56Cr |
| ROE | 1.09% |
| P/E Ratio(TTM) | -1.70 |
| EPS(TTM) | -6.62 |
| P/B Ratio | 0.67 |
| Dividend Yield | 0.00% |
| Industry P/E | 41.14 |
| Book Value | 16.71 |
| Debt to Equity | 0.03 |
| Face Value | 10 |
| Parent Organisation | Lasa Supergenerics |
| Managing Director | Dr. Omkar Herlekar |
| NSE Symbol | LASA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |